You have only highlighted certain part of concall. If you are following the company, they have always maintained that their 1.5 B USD aspiration has inorganic growth backed in as well. Recently they absorbed around 300 engineers from Forvia as part of a 45M Euro deal. Now they are not looking for any auto related acquisitions in Europe. The target is medtech in US now. Yes 1.5B USD is ambitious but not completely ruled out. Problem with LTTS off late is they are taking two steps forward and one step backward. They were doing well on margin and revenue front before they acquired SWC. They had to compromise on margin due to that. Now due to reorganizing in three verticals, they are again compromising on margin and you will see EBIT margin mostly going below 16% in first two quarters of FY25. So they have compromised on margins for growth in last two years which market has not taken kindly. In fact, in Q4FY24 they did growth 5.1 QoQ in CC which is really good but margin guidance did not go well with market and stock has been on downturn since then.
| Subscribe To Our Free Newsletter |
